PISCATAWAY, N.J. – Camber Pharmaceuticals is pleased to announce the addition of theophylline extended-release tablets to its current portfolio.

Theophylline extended-release tablets are indicated for the treatment of the symptoms and reversible airflow obstruction associated with chronic asthma and other chronic lung diseases.

Theophylline extended-release tablets are available in 300 mg and 450 mg strengths, both in 100 count bottles.  

To find out more about theophylline extended-release tablets, visit  https://www.camberpharma.com/theophylline-er